1:5 Stock Split Gets Approval: Small Cap Pharma Stock Soars 249% In 6-Months

Leading pharmaceuticals sector stock, Medico Remedies Ltd announced stock split in the ratio of 1:5. The board of directors of Medico Remedies Ltd will soon give intimation about record date. The stock gave multibagger return to shareholders in last 6-months and rallied 38% in last 3-months. Check details below:

1. Board of Medico Remedies Ltd Approves Stock Split

The board of directors of the company said in the BSE filing, "The Board considered the proposal for sub-division of 1 equity share of the Company having face value of ₹10/- each into 5 (Five) equity shares having face value of ₹2/- each, subject to regulatory/statutory approvals as may be required and the approval of the shareholders of the Company."

2. Medico Remedies Ltd Stock Performance & Return

The last trading price of the stock is Rs 316.05 apiece with an intraday rally of 1.30%. The stock's 52-week high is Rs 344.50 apiece and 52-week low is Rs 75.55 apiece, respectively.

The company has a market capitalisation of Rs 524.54 crore.

The stock rallied 38% in last 3-months, 249% in last 6-months, and 291% in last 1-year.

3. Medico Remedies About

Medico Remedies Limited is a pharmaceutical formulation manufacturing company with manufacturing and marketing capabilities in formulation with focus on anti-infective, Beta-Lactums, cephalosporins, antimalarial, antiretroviral, anti-ulcer drugs and antacids, vitamins, etc.

Disclaimer

The stock gives details related to stock split announcement. Greynium Information Technologies and the author are not liable for any losses caused as a result of decisions based on the article. Goodreturns.in advises users to check with certified experts before taking any investment decision.